A new study in the Journal of Health Psychology finds that the Body Roundness Index, a measure of belly fat, is linked to ...

People with cognitive decline or early-stage dementia saw their symptoms improve when given bespoke treatment plans that ...

Coffee can be more than just your morning pick-me-up, offering several health benefits. However, how you prepare your cup ...

Obesity has become one of the biggest health problems in the world today. It affects millions of people and increases the risk of serious diseases such as heart disease, type 2 diabetes, and certain ...

A Georgia State University study shows standard cognitive screening tools used to monitor Alzheimer's disease may not reflect underlying brain changes in the same way for women and men. According to ...

We call it "belly dancing," that alluring art form where dancers use their hips and torso in mesmerizing motion that is often seen as sensual and expressive. But in other places, the dance is referred ...

A high-dose flu vaccine was tied to a lower risk of Alzheimer's dementia in older adults versus standard-dose flu shots. The association persisted for the first 25 months after vaccination. The ...

Joseph Buxbaum was initially unconvinced. When early hints of a connection between autism and Alzheimer’s began to appear in the medical literature a few years ago, they struck him as implausible — ...

LeanBiome has exploded across women’s weight-loss discussions in 2026, driven by claims that a multi-strain probiotic blend, especially Lactobacillus gasseri, rhamnosus, fermentum, and the GreenSelect ...

As a neurologist, I routinely diagnose my Alzheimer’s patients early enough to intervene. I work to give them options: individualized treatment plans that might include an anti-inflammatory diet, ...

Add Yahoo as a preferred source to see more of our stories on Google. (koto_feja/Canva) Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering ...

Recent research has highlighted the role of neuroinflammation and vascular dysfunction in Alzheimer’s disease (AD). Semaglutide, a GLP-1 receptor agonist, has shown promise in reducing inflammation ...